Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy DOI
Hongwei Zhang, Linfu Chen, Qian Chen

и другие.

Advanced Healthcare Materials, Год журнала: 2024, Номер 14(1)

Опубликована: Ноя. 14, 2024

Abstract Tirapazamine (TPZ), an antitumor prodrug, can be activated in hypoxic environment. It specifically targets the microenvironment of tumors and produces toxic free radicals. However, due to tumor is not completely hypoxic, TPZ often fails effectively treat entire tissue, resulting suboptimal therapeutic outcomes. Herein, a low pathogenic Escherichia coli TOP10 utilized selectively colonize tissues, disrupt blood vessels, induce thrombus formation, leading expansion region improving effect TPZ. Additionally, thermosensitive hydrogel constructed by Pluronic F‐127 (F127), which undergoes gelation situ at site, sustained release To monitor process, it genetically modified integrating bioluminescent system luxCDABE (TOP10‐Lux). The signal associated with hypoxia enhancement beneficial for monitoring bioluminescence imaging. In murine colon cancer model, TOP10‐Lux combined TPZ‐loaded F127 suppressed growth, treatment process efficiently monitored. Together, this work employs enhance efficacy providing effective strategy bacteria‐based tumor‐targeted chemotherapy monitoring.

Язык: Английский

Hyaluronan-decorated copper-doxorubicin-anlotinib nanoconjugate for targeted synergistic chemo/chemodynamic/antiangiogenic tritherapy against hepatocellular carcinoma DOI
Gang Tan,

Guanghui Hou,

Junmin Qian

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 662, С. 857 - 869

Опубликована: Фев. 11, 2024

Язык: Английский

Процитировано

9

A Polyplatin with Hands‐Holding Near‐Infrared‐II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment Feedback DOI
Yingjie Yu, Dengshuai Wei,

Tiejun Bing

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(30)

Опубликована: Май 1, 2024

Abstract The in vivo fate of chemotherapeutic drugs plays a vital role understanding the therapeutic outcome, side effects, and mechanism. However, lack imaging abilities drugs, tedious labeling processes, premature leakage agents result loss fidelity between signals. Herein, an amphiphilic polymer is created by copolymerization near‐infrared‐II (NIR‐II) fluorophore tracer (T) anticancer Pt(IV) prodrug (D) cisplatin hand‐holding manner into one chain for first time. obtained Polyplatin DT capable delivering fluorophores concomitantly at precise D/T ratio, thereby resulting tracking platinum even readout them real‐time via NIR‐II imaging. can self‐assemble nanoparticles, referred to as Nanoplatin . Furthermore, caspase‐3 cleavable peptide that serves apoptosis reporter attached , DTR are simultaneously evaluating efficacy. Overall, it reported here design theranostic with drug tracers, efficacy reporters work concert provide insight mechanism action.

Язык: Английский

Процитировано

9

Carrier-Free Nanodrugs: From Bench to Bedside DOI

Fang Fang,

Xiaoyuan Chen

ACS Nano, Год журнала: 2024, Номер 18(35), С. 23827 - 23841

Опубликована: Авг. 20, 2024

Carrier-free nanodrugs with extraordinary active pharmaceutical ingredient (API) loading (even 100%), avoidable carrier-induced toxicity, and simple synthetic procedures are considered as one of the most promising candidates for disease theranostics. Substantial studies commercial success "carrier-free" nanocrystals have demonstrated their strong clinical potential. However, practical translations remain challenging impeded by unpredictable assembly processes, insufficient delivery efficiency, an unclear in vivo fate. In this Perspective, we systematically outline contemporary emerging carrier-free based on diverse APIs, well highlight opportunities challenges translation. Looking ahead, further improvements design preparation, drug delivery, efficacy, safety nanomedicines essential to facilitate translation from bench bedside.

Язык: Английский

Процитировано

9

Enzymatic metal oxide/nanoparticle heterojunctions with mutually reinforced bifunctional chemotherapies for combating drug-resistant bacteria DOI
Qian Zhou, Ting Wang, Zhenyu Xing

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 483, С. 149249 - 149249

Опубликована: Фев. 2, 2024

Язык: Английский

Процитировано

7

Quintuple Free‐Radical Therapy: An Ultralong‐Retention FAND for NIR‐Involved Multiple Site‐Acting Hypoxic Tumor Therapy DOI
Chuang Zhang, Dongxu Zhao, Fang Fang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер unknown

Опубликована: Июль 1, 2024

Abstract The heavy dependence on intratumoral O 2 and H availability has greatly restricted ROS‐based therapy. Although /H ‐irrelevant free‐radical nanogenerator garnered tremendous attention as a promising anticancer candidate to overcome the above intrinsic limitations of treatment, practical therapeutic efficacy therapy is still hindered by limited type inferior tumor retention performance. Herein, inspired new concept full‐API nanodrug (FAND) with 100% active pharmaceutical ingredient (API) content repurposing clinical anti‐malaria drug artesunate (ARTE) an generator, AFeI FANDs composed ARTE, human essential Fe 3+ , FDA‐approved fluorescent agent ICG for hypoxic are rationally designed constructed. Attractively, completely pharmaceutically components can be responsively liberated in acidic microenvironment synergistically produce five types free radicals including •O − •C, •OH, LOO•, 1 leading robust mitochondrial injury, nuclear DNA damage, lipid peroxides. More importantly, displayed ultralong longer than 108 h favorable suppression outcomes under mild NIR irradiation. Collectively, presented first paradigm FAND‐based quintuple expands horizons development clinically transferable nanomedicine

Язык: Английский

Процитировано

7

Ternary CD/Co3O4@MnCo2O4 heterojunction nanozymes for enhanced sonodynamic/NIR-II-photothermal/nanocatalytic therapy through triple amplification of ROS generation DOI
Zhenlin Zhang, Jinyan Hu, Weiwei Li

и другие.

Carbon, Год журнала: 2025, Номер unknown, С. 120118 - 120118

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

1

Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment DOI
Yuhan Wang, Chunyan Yue,

Mengyao Zhang

и другие.

Chemical Engineering Journal, Год журнала: 2022, Номер 452, С. 139108 - 139108

Опубликована: Сен. 8, 2022

Язык: Английский

Процитировано

29

Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel DOI

Jieyu Long,

Wanshan Hu, Tao Ren

и другие.

International Journal of Pharmaceutics, Год журнала: 2023, Номер 650, С. 123718 - 123718

Опубликована: Дек. 15, 2023

Язык: Английский

Процитировано

15

Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery DOI Creative Commons

Phattalapol Lhaglham,

Luksika Jiramonai,

Yaru Jia

и другие.

iScience, Год журнала: 2024, Номер 27(11), С. 111185 - 111185

Опубликована: Окт. 17, 2024

Язык: Английский

Процитировано

6

Injectable microenvironment-responsive hydrogels with redox-activatable supramolecular prodrugs mediate ferroptosis-immunotherapy for postoperative tumor treatment DOI Open Access
Zhuo Cheng,

Chencheng Xue,

Minghan Liu

и другие.

Acta Biomaterialia, Год журнала: 2023, Номер 169, С. 289 - 305

Опубликована: Авг. 5, 2023

Язык: Английский

Процитировано

13